SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-029971
Filing Date
2024-03-01
Accepted
2024-03-01 16:10:40
Documents
1
Group Members
AARON GLENN LOUIS FLETCHERBIOS ADVISORS GP, LLCBIOS CAPITAL MANAGEMENT, LPBIOS EQUITY PARTNERS II, LPBIOS FUND I QP, LPBIOS FUND I, LPBIOS FUND II NT, LPBIOS FUND II QP, LPBIOS FUND II, LPBP DIRECTORS, LPCAVU ADVISORS, LLCCAVU MANAGEMENT, LPLESLIE WAYNE K

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm247761d1_sc13da.htm SC 13D/A 317289
  Complete submission text file 0001104659-24-029971.txt   319429
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Subject) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91536 | Film No.: 24709781
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 817-381-5370
Bios Equity Partners, LP (Filed by) CIK: 0001813314 (see all company filings)

IRS No.: 822422973 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A